Beneficial effects of combined nifedipine and diltiazem for stable angina.
Tomonori Tateishi, Teruhiko Toyo‐oka, Nobuo Toyosaki, Kyoichi Ohashi, T. Yaginuma, Saichi Hosoda
Abstract
Open-access reader
Tomonori Tateishi, Teruhiko Toyo‐oka, Nobuo Toyosaki, Kyoichi Ohashi, T. Yaginuma, Saichi Hosoda
Abstract
Open-access reader
The antianginal effects of a combination of nifedipine and diltiazem were investigated in 6 patients with stable effort angina. Patients received one-week courses of successive treatment with 80 mg/day of nifedipine, 120 mg/day of nifedipine, then a combination of 120 mg/day of nifedipine and 120 mg/day of diltiazem, respectively. Patients then performed a symptom-limited treadmill exercise test at the end of each period of treatment. Mean exercise duration was 383 sec after receiving 80 mg/day of nifedipine 389 sec after receiving 120 mg/day of nifedipine and was then increased to 498 sec after receiving the nifedipine-diltiazem combination. The mean plasma nifedipine concentration at the end of one-week treatment increased from 134. 5 ng/ml during administration of 120 mg/day of nifedipine to 335.5 ng/ml during administration of the nifedipine-diltiazem combination. This study demonstrated that a combination of nifedipine and diltiazem is of value in the treatment of effort angina, partly because of an increase in the plasma nifedipine concentration as a result of the pharmacokinetic interaction between nifedipine and diltiazem.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The antianginal effects of a combination of nifedipine and diltiazem were investigated in 6 patients with stable effort angina. Patients received one-week courses of successive treatment with 80 mg/day of nifedipine, 120 mg/day of nifedipine, then a combination of 120 mg/day of nifedipine and 120 mg/day of diltiazem, respectively. Patients then performed a symptom-limited treadmill exercise test at the end of each period of treatment. Mean exercise duration was 383 sec after receiving 80 mg/day of nifedipine 389 sec after receiving 120 mg/day of nifedipine and was then increased to 498 sec after receiving the nifedipine-diltiazem combination. The mean plasma nifedipine concentration at the end of one-week treatment increased from 134. 5 ng/ml during administration of 120 mg/day of nifedipine to 335.5 ng/ml during administration of the nifedipine-diltiazem combination. This study demonstrated that a combination of nifedipine and diltiazem is of value in the treatment of effort angina, partly because of an increase in the plasma nifedipine concentration as a result of the pharmacokinetic interaction between nifedipine and diltiazem.
Key concepts: Nifedipine, Diltiazem, Medicine, Angina, Pharmacokinetics, Pharmacology, Anesthesia, Internal medicine